--2025/Q2-- / 14.255B--
--2025/Q1-- / 12.779B--
Feb 6, 20252024/Q413.533B / 13.431B--
Oct 30, 20242024/Q311.439B / 12.119B--
Overview | Strong demand for Mounjaro but prices dip, forecasts over 30% jump in 2025 sales on newer medicines
Currency:USDFeb 6, 2025
Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
Revenue | 13.43B | 13.53B | +101.55M |
Beat Est. | +43.60% | +44.68% | +0.76% |
EPS | 5.01 | 4.88 | -0.13 |
Miss Est. | +107.01% | +101.65% | -2.59% |
Feb 15, 2025
Revenue
EPS
EBIT
Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Unlock Free Earnings Estimates
Read more